Achieving optimal results with standard balloon angioplasty: Can baseline and angiographic variables predict stent-like outcomes?

Journal of the American College of Cardiology

Volumn 37, Issue 7, 2001, Pages 1883-1890

  Cantor, Warren J ^a   Hellkamp, Anne S ^b   Peterson, Eric D ^b   Zidar, James P ^b   Cowper, Patricia A ^b   Sketch Jr , Michael H ^b   Tcheng, James E ^b   Califf, Robert M ^b   Ohman, E Magnus ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; ARTICLE; CORONARY STENT; FEMALE; HEALTH CARE COST; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION;

ANGIOPLASTY, BALLOON; CORONARY DISEASE; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; STENTS;

EID: 0035368472     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01244-X     Document Type: Article

References (50)

1. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease
2. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
3. Acute and long-term cost implications of coronary stenting
4. A call for provisional stenting: The balloon is back
5. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease
6. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
7. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrelin to Minimise Platelet Aggregation and Coronary Thrombosis-II
8. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril
9. A randomized comparison of the effects of gradual prolonged versus standard primary balloon inflation on early and late outcome. Results of a multicenter clinical trial
10. Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions
11. Technologic considerations and practical limitations in the use of quantitative angiography during percutaneous coronary recanalization
12. Automated quantitative coronary arteriography: Morphologic and physiologic validation in vivo of a rapid digital angiographic method
13. Acute and long-term outcome after Palmaz-Schatz stenting: Analysis from the New Approaches to Coronary Intervention (NACI) registry
14. Predictive factors of restenosis after coronary stent placement
15. A call for professional stenting: The balloon is dead and buried!
16. Dealing with in-stent restenosis
17. In-stent restenosis: The Washington Hospital Center experience
18. In-Stent Restenosis: "The great equalizer" - Disappointing clinical outcomes with ALL interventional strategies
19. Provisional stenting - Stent-like balloon angioplasty: Evidence to define the continuing role of balloon angioplasty for percutaneous coronary revascularization
20. Do superior balloon angioplasty results provide stent-like outcomes in coronary occlusions?
21. Long-term follow-up of post-PTCA results (≤ 30% residual diamter stenosis) in the restenotic lesions: Results of the REST trial
22. Long-term analysis of conventional balloon angioplasty and an initial "stent-like" result: The NHLBI PTCA Registry
23. Ten year follow-up of patients with optimal "stent-like," suboptimal or failed coronary angioplasty
24. Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): A randomised trial
25. Balloon Optimization versus Stent Study (BOSS): Provisional stenting and early recoil after balloon angioplasty
26. Optimal Coronary Balloon Angioplasty with provisional Stenting versus primary stent (OCBAS): Immediate and long-term follow-up results
27. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- And long-term outcomes of coronary balloon angioplasty: The DEBATE study (Doppler Endpoints Balloon Angioplasty Trial Europe)
28. Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement
29. The French randomized optimal stenting trial: A prospective evaluation of provisional stenting guided by coronary velocity reserve and quantitative coronary angiography
30. Randomized comparison of elective stent implantation and coronary balloon angioplasty guided by online quantitative angiography and intracoronary Doppler
31. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty
32. Clinical outcome improvements from coronary stenting: A systemic overview
33. The ESPRIT study: A randomised, placebo-controlled trial of a novel dosing regimen of eptifibatide in planned coronary stent implantation
34. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicentre randomised trial
35. Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery
36. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: Results from a randomized clinical trial
37. In-hospital costs associated with new percutaneous coronary devices
38. Restenosis after coronary angioplasty: A multivariate statistical model to relate lesion and procedure variables to restenosis
39. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome
40. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty
41. Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty, for unstable angina pectoris
42. Restenosis after successful coronary angioplasty in patients with single-vessel disease
43. Can restenosis after coronary angioplasty be predicted from clinical variables?
44. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung, and Blood Institute
45. Multilesion coronary angioplasty: Clinical and angiographic follow-up
46. Restenosis after coronary angioplasty: An overview
47. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty
48. Higher mortality in women following angioplasty explained by differences in body size, not vessel size
49. Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty - A report from the M-HEART Group
50. Restenosis: The clinical issues